Baxter International BAX

$25.74 -0.60 (-2.28%)

Valuation

Market cap
13,626,948,000
Revenue TTM
$11,244,000,000
Net income TTM
$-957,000,000
P/E (trailing)
13.62
P/E (forward)
12.60
Profit margin
-8.51%
Debt to equity
1.33

Trading

Volume
4,668,667
Avg volume
6,900,858
Day's range
$25.65 – $26.66
Shares out
517,348,000
Stochastic %K
65%
Beta
0.68
Analysts
Hold
Price target
$25.85

Price

Company profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgi...

Show more

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
224 948 2000
Website
https://www.baxter.com
Address
One Baxter Parkway, Deerfield, United States

Latest news

Stocktwits

TheChartiste Nov 7, 6:04 PM
$BAX weekly
0 replies
GTA_Terminal Nov 7, 10:25 AM
Dark pool check on $BAX: what traded off the exchanges this session. Price barely moved (+0.5%), which is what you'd expect if somebody big is building or unwinding a position quietly. Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days: https://globaltradersacademy.com/start-trial?a=stocktwits&sym=BAX&utm_source=stocktwits&utm_medium=social&utm_campaign=trial&utm_content=BAX Read the full article for the full details: https://globaltradersacademy.com/articles/dark-pool-check-baxter-international-bax?utm_source=stocktwits&utm_medium=social
0 replies
ThePieIsALie Nov 6, 10:24 AM
$BAX no short, but the whole world can see they are short.. https://shortagewatch.org/medicine/ifosfamide/
0 replies
TheTradingAnalyst Nov 5, 6:49 AM
$BAX with a bullish setup... $SPX $SPY $QQQ $VIX Nice setup. Great opportunity to participate in the next up leg. Good luck. Real-time alerts at https://thetradinganalyst.com
0 replies
TalkMarkets Nov 3, 11:51 PM
“Healthy Strides” Stock Market (And Sentiment Results) $VFC $BAX https://talkmarkets.com/article/healthy-strides-stock-market-and-sentiment-results
0 replies
Netlinetli Nov 3, 4:00 PM
$ICU $BAX $MCK $JNJ $MRNA so how can you explain there are no investors? Bleeding everyday since big announcemnt on important conference? All those guys who are rich AF , doctors, people from pharma business etc. They have plenty of money, they know the „news” and understand the potential of medical devices better than anyone. Why they dont give a f** about this company ???
2 replies
SparkyReturns Nov 3, 3:50 PM
$ICU Sitting at a mere 10M Market Cap, Seastar (ICU) will generate more revenue than that in 2027 with today's removal of the registry requirement. 7 BDDs, with the most recent for Sepsis as a standalone indication. TAM easily in the billions once adult use approved in early/mid-2027. Pediatric already approved under HDE. Incredibly underpriced. Related biotechs that supply tubing, equipment, and medicines for Sepsis, AKI, cancer, and heart disease could also be affected. https://investors.seastarmedical.com/news-releases/news-release-details/fda-confirms-seastar-medical-has-fulfilled-post-approval-study $BAX $MCK $JNJ $MRNA
0 replies
KryptonResearch14 Oct 31, 3:38 PM
$BAX Baxter's long contract book is shrinking while sales grow. Transaction price allocated to remaining performance obligations on executed contracts over one year was 7.58 billion dollars at Sep 30, down from 8.50 billion at year end and 8.87 billion at Mar 31. Only about 10 percent of that is scheduled to convert in the rest of 2026, with 25 percent in 2027. Medical Products and Therapies, where these contracts sit, did 2,102 million dollars of sales in Q3.
0 replies